Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
7.70
-0.23 (-2.90%)
At close: Mar 6, 2026, 4:00 PM EST
7.85
+0.15 (1.95%)
After-hours: Mar 6, 2026, 4:25 PM EST
Fennec Pharmaceuticals Employees
Fennec Pharmaceuticals had 32 employees as of December 31, 2024. The number of employees increased by 3 or 10.34% compared to the previous year.
Employees
32
Change (1Y)
3
Growth (1Y)
10.34%
Revenue / Employee
$1,212,188
Profits / Employee
-$216,844
Market Cap
262.98M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 222 |
| AC Immune | 172 |
| Coherus Oncology | 158 |
| Abeona Therapeutics | 136 |
| Prelude Therapeutics | 131 |
| OmniAb | 114 |
| Enlivex | 71 |
| Cybin | 50 |
FENC News
- 3 days ago - Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute - GlobeNewsWire
- 2 months ago - Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) - GlobeNewsWire
- 2 months ago - Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026 - Seeking Alpha
- 3 months ago - Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors - GlobeNewsWire
- 3 months ago - Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss - GlobeNewsWire
- 3 months ago - Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Fennec Pharmaceuticals Announces Closing of Offering of Common Shares - GlobeNewsWire
- 4 months ago - Fennec Pharmaceuticals Announces Private Offering of Common Shares in Canada - GlobeNewsWire